Evidence map›Paper›PMID 38231428›Full record

ArticleJournal of robotic surgery2024

Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group).

Masahiro Toide, Shin Ebara, Tomoyuki Tatenuma, Yoshinori Ikehata, Akinori Nakayama, Makoto Kawase, Takeshi Sasaki, Tatsuaki Yoneda, Kazushige Sakaguchi, Jun Teishima and 7 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Visceral Fat Volume and Inguinal Hernia After Robot-Assisted Radical Prostatectomy: A Three-Dimensional CT Analysis.International journal of urology : official journal of the Japanese Urological Association · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Masahiro ToideDepartment of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan.
Shin EbaraDepartment of Urology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Tomoyuki TatenumaDepartment of Urology, Yokohama City University, Yokohama, Japan.
Yoshinori IkehataDepartment of Urology, University of Toyama, Toyama, Japan.
Akinori NakayamaDepartment of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Makoto KawaseDepartment of Urology, Gifu University Graduate School of Medicine, Gifu, Japan.
Takeshi SasakiDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Japan.
Tatsuaki YonedaDepartment of Urology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Kazushige SakaguchiDepartment of Urology, Toranomon Hospital, Tokyo, Japan.
Jun TeishimaDepartment of Surgery, Division of Urology, Graduate School of Medicine, Kobe University, Kobe, Japan.
Kazuhide MakiyamaDepartment of Urology, Yokohama City University, Yokohama, Japan.
Hiroshi KitamuraDepartment of Urology, University of Toyama, Toyama, Japan.
Kazutaka SaitoDepartment of Urology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Takuya KoieDepartment of Urology, Gifu University Graduate School of Medicine, Gifu, Japan.
Takahiro InoueDepartment of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu, Japan.
Shinji UrakamiDepartment of Urology, Toranomon Hospital, Tokyo, Japan.
Fumitaka KogaDepartment of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-8677, Japan. fumitaka_koga@tmhp.jp.ORCID http://orcid.org/0000-0001-7888-0085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the incidence and risk factors of inguinal hernia (IH) after robot-assisted radical prostatectomy (RARP) using a multicentric database. The present study used a multicentric database (the MSUG94) containing data on 3,195 Japanese patients undergoing RARP between 2012 and 2021. Surgical procedures utilized for IH prevention were as follows: isolation of the vas deferens, transection of the vas deferens, isolation of the spermatic vessels, and separation of the peritoneum from the internal inguinal ring. The primary and secondary endpoints were IH-free survival and any association between post-RARP IH and clinical covariates. The prophylactic effect of the above procedures were also assessed. IH prevention was attempted in 1,465 (46.4%) patients at five of the nine hospitals. During follow-up (median 24 months), post-RARP IH developed in 243 patients. The post-RARP IH-free survival rates at years 1, 2, and 3 were 94.3%, 91.7%, and 90.5%, respectively. Old age (hazard ratio [HR] 1.037; 95% confidence interval [CI] 1.014-1.061; p = 0.001), low BMI (HR 0.904; 95% CI 0.863-0.946: p < 0.001), and low hospital volume (HR 1.385; 95% CI 1.003-1.902; p = 0.048) were independently associated with IH development. None of the procedures for IH prevention were associated with IH development. Our findings may represent the current, real-world status of post-RARP IH in Japan. The prophylactic effects of the surgical procedures for IH prevention should be further investigated in well-designed, prospective studies to optimize the surgical technique.

Indexed as

Hernia, InguinalRoboticsRobotic Surgical ProceduresCohort StudiesHumansIncidenceJapanMaleProstatectomyRetrospective StudiesRisk FactorsInguinal herniaMulticenter studyProstate cancerRadical prostatectomyRobot-assisted radical prostatectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.